1	Hombre	hombre	NCMS000	C0025266#C0086418#C0043210	persona#organismo_vivo	0-6	101_QUEST_clinical_caseMIR	SENT1	-	-
2	de	de	SPS00	C0332285	atributo	7-9	101_QUEST_clinical_caseMIR	SENT1	-	-
3	20	20		-	-	10-12	101_QUEST_clinical_caseMIR	SENT1	-	-
4	años	año	NCMP000	C0439234	calificador	13-17	101_QUEST_clinical_caseMIR	SENT1	-	-
5	previamente	previamente	RG	-	-	18-29	101_QUEST_clinical_caseMIR	SENT1	-	-
6	sano	sano	AQ0MS0	-	-	30-34	101_QUEST_clinical_caseMIR	SENT1	-	-
7	y	y	CC	C1706368	calificador	35-36	101_QUEST_clinical_caseMIR	SENT1	-	-
8	sin	sin	SPS00	C0332288	atributo	37-40	101_QUEST_clinical_caseMIR	SENT1	-	-
9	antecedentes	antecedente	NCMP000	-	-	41-53	101_QUEST_clinical_caseMIR	SENT1	-	-
10	personales	personal	AQ0CP0	-	-	54-64	101_QUEST_clinical_caseMIR	SENT1	-	-
11	de	de	SPS00	C0332285	atributo	65-67	101_QUEST_clinical_caseMIR	SENT1	-	-
12	interés	interés	NCMS000	-	-	68-75	101_QUEST_clinical_caseMIR	SENT1	-	-
13	que	que	PR0CN000	-	-	76-79	101_QUEST_clinical_caseMIR	SENT1	-	-
14	es	ser	VSIP3S0	-	-	80-82	101_QUEST_clinical_caseMIR	SENT1	-	-
15	llevado	llevar	VMP00SM	-	-	83-90	101_QUEST_clinical_caseMIR	SENT1	-	-
16	al	al	SP+DA	-	-	91-93	101_QUEST_clinical_caseMIR	SENT1	-	-
17	servicio	servicio	NCMS000	-	-	94-102	101_QUEST_clinical_caseMIR	SENT1	-	-
18	de	de	SPS00	C0332285	atributo	103-105	101_QUEST_clinical_caseMIR	SENT1	-	-
19	urgencias	urgencia	NCFP000	C0439609	calificador	106-115	101_QUEST_clinical_caseMIR	SENT1	-	-
20	por	por	SPS00	C0678226	atributo	116-119	101_QUEST_clinical_caseMIR	SENT1	-	-
21	presentar	presentar	VMN0000	-	-	120-129	101_QUEST_clinical_caseMIR	SENT1	-	-
22	agitación	agitación	NCFS000	C0085631	hallazgo	130-139	101_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
23	durante	durante	SPS00	C1444752#C0347984	atributo	140-147	101_QUEST_clinical_caseMIR	SENT1	-	-
24	las	el	DA0FP0	-	-	148-151	101_QUEST_clinical_caseMIR	SENT1	-	-
25	últimas	último	AO0FP0	-	-	152-159	101_QUEST_clinical_caseMIR	SENT1	-	-
26	24	24	Z	C0439584_1	calificador_1	160-162	101_QUEST_clinical_caseMIR	SENT1	-	-
27	horas	hora	NCFP000	C0439584_2	calificador_2	163-168	101_QUEST_clinical_caseMIR	SENT1	-	-
28	.	.	Fp	-	-	168-169	101_QUEST_clinical_caseMIR	SENT1	-	-

1	Durante	durante	SPS00	C1444752#C0347984	atributo	170-177	101_QUEST_clinical_caseMIR	SENT2	-	-
2	la	el	DA0FS0	-	-	178-180	101_QUEST_clinical_caseMIR	SENT2	-	-
3	semana	semana	NCFS000	C0439230	calificador	181-187	101_QUEST_clinical_caseMIR	SENT2	-	-
4	previa	previo	AQ0FS0	C0205156	calificador	188-194	101_QUEST_clinical_caseMIR	SENT2	-	-
5	sus	su	DP3CP0	-	-	195-198	101_QUEST_clinical_caseMIR	SENT2	-	-
6	familiares	familiar	NCMP000	C0080103#C0241888	persona#calificador	199-209	101_QUEST_clinical_caseMIR	SENT2	-	-
7	le	le	PP3CSD00	C1292157#C0409974	hallazgo#trastorno	210-212	101_QUEST_clinical_caseMIR	SENT2	-	-
8	han	haber	VAIP3P0	-	-	213-216	101_QUEST_clinical_caseMIR	SENT2	-	-
9	notado	notar	VMP00SM	-	-	217-223	101_QUEST_clinical_caseMIR	SENT2	-	-
10	coloración	coloración	NCFS000	C0013343#C0038128	sustancia	224-234	101_QUEST_clinical_caseMIR	SENT2	-	-
11	amarillenta	amarillento	AQ0FS0	-	-	235-246	101_QUEST_clinical_caseMIR	SENT2	-	-
12	de	de	SPS00	C0332285	atributo	247-249	101_QUEST_clinical_caseMIR	SENT2	-	-
13	piel	piel	NCFS000	C1278993#C0037262#C1123023	estructura_corporal	250-254	101_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
14	y	y	CC	C1706368	calificador	255-256	101_QUEST_clinical_caseMIR	SENT2	-	-
15	de	de	SPS00	C0332285	atributo	257-259	101_QUEST_clinical_caseMIR	SENT2	-	-
16	conjuntivas	conjuntiva	NCFP000	C1278888#C1285698#C0009758	estructura_corporal#entidad_observable	260-271	101_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
17	.	.	Fp	-	-	271-272	101_QUEST_clinical_caseMIR	SENT2	-	-

1	Consumidor	consumidor	NCMS000	-	-	273-283	101_QUEST_clinical_caseMIR	SENT3	B-Grp_Enfermedad	-
2	ocasional	ocasional	AQ0CS0	C0521114	calificador	284-293	101_QUEST_clinical_caseMIR	SENT3	-	-
3	de	de	SPS00	C0332285	atributo	294-296	101_QUEST_clinical_caseMIR	SENT3	-	-
4	cocaína	cocaína	NCFS000	C0009170	sustancia	297-304	101_QUEST_clinical_caseMIR	SENT3	B-Grp_Medicamento	-
5	y	y	CC	C1706368	calificador	305-306	101_QUEST_clinical_caseMIR	SENT3	-	-
6	éxtasis	éxtasis	NCMN000	C0678156	hallazgo	307-314	101_QUEST_clinical_caseMIR	SENT3	-	-
7	y	y	CC	C1706368	calificador	315-316	101_QUEST_clinical_caseMIR	SENT3	-	-
8	los	el	DA0MP0	-	-	317-320	101_QUEST_clinical_caseMIR	SENT3	-	-
9	fines	fin	NCMP000	-	-	321-326	101_QUEST_clinical_caseMIR	SENT3	-	-
10	de	de	SPS00	C0332285	atributo	327-329	101_QUEST_clinical_caseMIR	SENT3	-	-
11	semana	semana	NCFS000	C0439230	calificador	330-336	101_QUEST_clinical_caseMIR	SENT3	-	-
12	de	de	SPS00	C0332285	atributo	337-339	101_QUEST_clinical_caseMIR	SENT3	-	-
13	alcohol	alcohol	NCMS000	C0001975	sustancia	340-347	101_QUEST_clinical_caseMIR	SENT3	B-Grp_Medicamento	-
14	(	(	Fpa	-	-	348-349	101_QUEST_clinical_caseMIR	SENT3	-	-
15	20	20	Z	-	-	349-351	101_QUEST_clinical_caseMIR	SENT3	-	-
16	gramos	g	NCMP000	-	-	352-358	101_QUEST_clinical_caseMIR	SENT3	-	-
17	)	)	Fpt	-	-	358-359	101_QUEST_clinical_caseMIR	SENT3	-	-
18	.	.	Fp	-	-	359-360	101_QUEST_clinical_caseMIR	SENT3	-	-

1	Mantiene	mantener	VMIP3S0	-	-	361-369	101_QUEST_clinical_caseMIR	SENT4	-	-
2	relaciones	relación	NCFP000	C0456603#C0439849#C3645603	calificador#atributo#metadato_fundacional	370-380	101_QUEST_clinical_caseMIR	SENT4	-	-
3	sexuales	sexual	AQ0CP0	-	-	381-389	101_QUEST_clinical_caseMIR	SENT4	-	-
4	de	de	SPS00	C0332285	atributo	390-392	101_QUEST_clinical_caseMIR	SENT4	-	-
5	riesgo	riesgo	NCMS000	-	-	393-399	101_QUEST_clinical_caseMIR	SENT4	-	-
6	sin	sin	SPS00	C0332288	atributo	400-403	101_QUEST_clinical_caseMIR	SENT4	-	-
7	protección	protección	NCFS000	-	-	404-414	101_QUEST_clinical_caseMIR	SENT4	-	-
8	adecuada	adecuar	VMP00SF	-	-	415-423	101_QUEST_clinical_caseMIR	SENT4	-	-
9	.	.	Fp	-	-	423-424	101_QUEST_clinical_caseMIR	SENT4	-	-

1	Temperatura	temperatura	NCFS000	C0039476	atributo	425-436	101_QUEST_clinical_caseMIR	SENT5	-	-
2	37°C	37°C		-	-	437-441	101_QUEST_clinical_caseMIR	SENT5	-	-
3	.	.	Fp	-	-	441-442	101_QUEST_clinical_caseMIR	SENT5	-	-

1	Presión	presión	NCFS000	C0005823#C1272641_1	entidad_observable_1	443-450	101_QUEST_clinical_caseMIR	SENT6	-	-
2	arterial	arterial	NC00SC0	C0005823#C1272641_2	entidad_observable_2	451-459	101_QUEST_clinical_caseMIR	SENT6	B-Estructura_Corporal	-
3	110/60	110/60	Z	-	-	460-466	101_QUEST_clinical_caseMIR	SENT6	-	-
4	mmHg	mmHg	NCMP000	-	-	467-471	101_QUEST_clinical_caseMIR	SENT6	-	-
5	.	.	Fp	-	-	471-472	101_QUEST_clinical_caseMIR	SENT6	-	-

1	En	en	SPS00	C1720294#C0332285	calificador#atributo	473-475	101_QUEST_clinical_caseMIR	SENT7	-	-
2	la	el	DA0FS0	-	-	476-478	101_QUEST_clinical_caseMIR	SENT7	-	-
3	exploración	exploración	NCFS000	C0031809_1	procedimiento_1	479-490	101_QUEST_clinical_caseMIR	SENT7	-	-
4	física	físico	NCFS000	C0031809_2	procedimiento_2	491-497	101_QUEST_clinical_caseMIR	SENT7	-	-
5	se	se	P00CN000	-	-	498-500	101_QUEST_clinical_caseMIR	SENT7	-	-
6	observa	observar	VMIP3S0	-	-	501-508	101_QUEST_clinical_caseMIR	SENT7	-	-
7	agitación	agitación	NCFS000	C0085631_1	hallazgo_1	509-518	101_QUEST_clinical_caseMIR	SENT7	B-Grp_Enfermedad	-
8	psicomotriz	psicomotriz	AQ0FS0	C0085631_2	hallazgo_2	519-530	101_QUEST_clinical_caseMIR	SENT7	B-Calificador	-
9	y	y	CC	C1706368	calificador	531-532	101_QUEST_clinical_caseMIR	SENT7	-	-
10	desorientación	desorientación	NCFS000	C0233407	hallazgo	533-547	101_QUEST_clinical_caseMIR	SENT7	B-Grp_Enfermedad	-
11	en	en	SPS00	C1720294#C0332285	calificador#atributo	548-550	101_QUEST_clinical_caseMIR	SENT7	B-Calificador	-
12	tiempo	tiempo	NCMS000	C0040223#C3541383	calificador#atributo#metadato_fundacional	551-557	101_QUEST_clinical_caseMIR	SENT7	I-Calificador	-
13	y	y	CC	C1706368	calificador	558-559	101_QUEST_clinical_caseMIR	SENT7	-	-
14	en	en	SPS00	C1720294#C0332285	calificador#atributo	560-562	101_QUEST_clinical_caseMIR	SENT7	-	-
15	espacio	espacio	NCMS000	-	-	563-570	101_QUEST_clinical_caseMIR	SENT7	-	-
16	,	,	Fc	-	-	570-571	101_QUEST_clinical_caseMIR	SENT7	-	-
17	asterixis	asterixis	NC00SC0	C0232766	hallazgo	572-581	101_QUEST_clinical_caseMIR	SENT7	B-Grp_Enfermedad	-
18	e	y	CC	C1706368	calificador	582-583	101_QUEST_clinical_caseMIR	SENT7	-	-
19	ictericia	ictericia	NCFS000	C0022346	hallazgo	584-593	101_QUEST_clinical_caseMIR	SENT7	B-Grp_Enfermedad	-
20	en	en	SPS00	C1720294#C0332285	calificador#atributo	594-596	101_QUEST_clinical_caseMIR	SENT7	-	-
21	piel	piel	NCFS000	C1278993#C0037262#C1123023	estructura_corporal	597-601	101_QUEST_clinical_caseMIR	SENT7	B-Estructura_Corporal	-
22	y	y	CC	C1706368	calificador	602-603	101_QUEST_clinical_caseMIR	SENT7	-	-
23	mucosas	mucosa	NCFP000	C0026724	estructura_corporal	604-611	101_QUEST_clinical_caseMIR	SENT7	B-Estructura_Corporal	-
24	,	,	Fc	-	-	611-612	101_QUEST_clinical_caseMIR	SENT7	-	-
25	gingivorragias	gingivorragia	NCFP000	-	-	613-627	101_QUEST_clinical_caseMIR	SENT7	B-Grp_Enfermedad	-
26	y	y	CC	C1706368	calificador	628-629	101_QUEST_clinical_caseMIR	SENT7	-	-
27	epistaxis	epistaxis	NCFN000	C0014591	trastorno	630-639	101_QUEST_clinical_caseMIR	SENT7	B-Grp_Enfermedad	-
28	.	.	Fp	-	-	639-640	101_QUEST_clinical_caseMIR	SENT7	-	-

1	El	el	DA0MS0	-	-	641-643	101_QUEST_clinical_caseMIR	SENT8	-	-
2	resto	resto	NCMS000	-	-	644-649	101_QUEST_clinical_caseMIR	SENT8	-	-
3	de	de	SPS00	C0332285	atributo	650-652	101_QUEST_clinical_caseMIR	SENT8	-	-
4	la	el	DA0FS0	-	-	653-655	101_QUEST_clinical_caseMIR	SENT8	-	-
5	exploración	exploración	NCFS000	C0031809_1	procedimiento_1	656-667	101_QUEST_clinical_caseMIR	SENT8	-	-
6	física	físico	NCFS000	C0031809_2	procedimiento_2	668-674	101_QUEST_clinical_caseMIR	SENT8	-	-
7	sin	sin	SPS00	C0332288	atributo	675-678	101_QUEST_clinical_caseMIR	SENT8	-	-
8	datos	dato	NCMP000	-	-	679-684	101_QUEST_clinical_caseMIR	SENT8	-	-
9	patológicos	patológico	AQ0MP0	C1521733	calificador	685-696	101_QUEST_clinical_caseMIR	SENT8	-	-
10	.	.	Fp	-	-	696-697	101_QUEST_clinical_caseMIR	SENT8	-	-

1	Las	el	DA0FP0	-	-	698-701	101_QUEST_clinical_caseMIR	SENT9	-	-
2	pruebas	prueba	NCFP000	-	-	702-709	101_QUEST_clinical_caseMIR	SENT9	-	-
3	de	de	SPS00	C0332285	atributo	710-712	101_QUEST_clinical_caseMIR	SENT9	-	-
4	laboratorio	laboratorio	NCMS000	C0022877	medio_ambiente	713-724	101_QUEST_clinical_caseMIR	SENT9	-	-
5	demuestran	demostrar	VMIP3P0	-	-	725-735	101_QUEST_clinical_caseMIR	SENT9	-	-
6	hiperbilirrubinemia	hiperbilirrubinemia	NC00SC0	C0020433	trastorno	736-755	101_QUEST_clinical_caseMIR	SENT9	B-Grp_Enfermedad	-
7	(	(	Fpa	-	-	756-757	101_QUEST_clinical_caseMIR	SENT9	-	-
8	25	25	Z	-	-	757-759	101_QUEST_clinical_caseMIR	SENT9	-	-
9	mg	mg	NCMN000	-	-	760-762	101_QUEST_clinical_caseMIR	SENT9	-	-
10	/	/	Fh	-	-	762-763	101_QUEST_clinical_caseMIR	SENT9	-	-
11	dl	decilitro	NCMN000	C0439241	calificador	763-765	101_QUEST_clinical_caseMIR	SENT9	-	-
12	)	)	Fpt	-	-	765-766	101_QUEST_clinical_caseMIR	SENT9	-	-
13	,	,	Fc	-	-	766-767	101_QUEST_clinical_caseMIR	SENT9	-	-
14	ALT	alanina_aminotransferasa_(o_tgp)	NC00YL0	-	-	768-771	101_QUEST_clinical_caseMIR	SENT9	-	-
15	(	(	Fpa	-	-	772-773	101_QUEST_clinical_caseMIR	SENT9	-	-
16	GPT	glutamic_pyruvic_transaminase_(transaminasa_glutámico_pirúvica)	NC00YL0	-	-	773-776	101_QUEST_clinical_caseMIR	SENT9	-	-
17	)	)	Fpt	-	-	776-777	101_QUEST_clinical_caseMIR	SENT9	-	-
18	y	y	CC	C1706368	calificador	778-779	101_QUEST_clinical_caseMIR	SENT9	-	-
19	AST	aspartato_transaminasa	NC00YL0	-	-	780-783	101_QUEST_clinical_caseMIR	SENT9	-	-
20	(	(	Fpa	-	-	784-785	101_QUEST_clinical_caseMIR	SENT9	-	-
21	GOT	glutámic_oxaloacetic_transaminase_(transaminasa_glutámico_oxalacética)	NC00YL0	-	-	785-788	101_QUEST_clinical_caseMIR	SENT9	-	-
22	)	)	Fpt	-	-	788-789	101_QUEST_clinical_caseMIR	SENT9	-	-
23	mayores	mayor	AQ0CP0	C0205164#C1704243#C0549177	calificador	790-797	101_QUEST_clinical_caseMIR	SENT9	-	-
24	de	de	SPS00	C0332285	atributo	798-800	101_QUEST_clinical_caseMIR	SENT9	-	-
25	1000	1000		-	-	801-805	101_QUEST_clinical_caseMIR	SENT9	-	-
26	UI	ui	NC00SC0	C0439453	calificador	806-808	101_QUEST_clinical_caseMIR	SENT9	-	-
27	/	/	Fh	-	-	808-809	101_QUEST_clinical_caseMIR	SENT9	-	-
28	L	l	NCFS000	-	-	809-810	101_QUEST_clinical_caseMIR	SENT9	-	-
29	;	;	Fx	-	-	810-811	101_QUEST_clinical_caseMIR	SENT9	-	-
30	prolongación	prolongación	NCFS000	-	-	812-824	101_QUEST_clinical_caseMIR	SENT9	-	-
31	del	del	SP+DA	-	-	825-828	101_QUEST_clinical_caseMIR	SENT9	-	-
32	tiempo	tiempo	NCMS000	C0033707_1	procedimiento_1	829-835	101_QUEST_clinical_caseMIR	SENT9	-	-
33	de	de	SPS00	C0033707_2	procedimiento_2	836-838	101_QUEST_clinical_caseMIR	SENT9	-	-
34	protrombina	protrombina	NCFS000	C0033707_3	procedimiento_3	839-850	101_QUEST_clinical_caseMIR	SENT9	-	-
35	(	(	Fpa	-	-	851-852	101_QUEST_clinical_caseMIR	SENT9	-	-
36	actividad	actividad	NCFS000	C0441655	entidad_observable	852-861	101_QUEST_clinical_caseMIR	SENT9	-	-
37	<	<	Fz	-	-	862-863	101_QUEST_clinical_caseMIR	SENT9	-	-
38	40	40	Z	-	-	864-866	101_QUEST_clinical_caseMIR	SENT9	-	-
39	%	%	Ft	-	-	866-867	101_QUEST_clinical_caseMIR	SENT9	-	-
40	,	,	Fc	-	-	867-868	101_QUEST_clinical_caseMIR	SENT9	-	-
41	INR	international_normalized_ratio	NC00YL0	-	-	869-872	101_QUEST_clinical_caseMIR	SENT9	-	-
42	1	1		-	-	873-874	101_QUEST_clinical_caseMIR	SENT9	-	-
43	5	5		-	-	875-876	101_QUEST_clinical_caseMIR	SENT9	-	-
44	)	)	Fpt	-	-	876-877	101_QUEST_clinical_caseMIR	SENT9	-	-
45	.	.	Fp	-	-	877-878	101_QUEST_clinical_caseMIR	SENT9	-	-

1	Indique	indicar	VMM03S0	-	-	879-886	101_QUEST_clinical_caseMIR	SENT10	-	-
2	el	el	DA0MS0	-	-	887-889	101_QUEST_clinical_caseMIR	SENT10	-	-
3	diagnóstico	diagnóstico	NCMS000	C0011900	entidad_observable	890-901	101_QUEST_clinical_caseMIR	SENT10	-	-
4	más	más	RG	C0205172	calificador	902-905	101_QUEST_clinical_caseMIR	SENT10	-	-
5	probable	probable	AQ0CS0	C0332148	calificador	906-914	101_QUEST_clinical_caseMIR	SENT10	-	-
6	del	del	SP+DA	-	-	915-918	101_QUEST_clinical_caseMIR	SENT10	-	-
7	cuadro	cuadro	NCMS000	-	-	919-925	101_QUEST_clinical_caseMIR	SENT10	-	-
8	que	que	PR0CN000	-	-	926-929	101_QUEST_clinical_caseMIR	SENT10	-	-
9	presenta	presentar	VMIP3S0	-	-	930-938	101_QUEST_clinical_caseMIR	SENT10	-	-
10	el	el	DA0MS0	-	-	939-941	101_QUEST_clinical_caseMIR	SENT10	-	-
11	paciente	paciente	NCCS000	C0030705	persona	942-950	101_QUEST_clinical_caseMIR	SENT10	-	-
12	.	.	Fp	-	-	950-951	101_QUEST_clinical_caseMIR	SENT10	-	-

